| Emma Kubik, NNP | |
|
4745 Ogletown Stanton Rd Ste 217, Newark, DE 19713-2074 | |
| (302) 733-2410 | |
| (302) 733-2602 |
| Full Name | Emma Kubik |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Neonatal |
| Location | 4745 Ogletown Stanton Rd Ste 217, Newark, Delaware |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093307696 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | L1-0054031 (Delaware) | Secondary |
| 363LN0000X | Nurse Practitioner - Neonatal | LM-0010179 (Delaware) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Emma Kubik, NNP 4745 Ogletown Stanton Rd Ste 217, Newark, DE 19713-2074 Ph: (302) 733-2410 | Emma Kubik, NNP 4745 Ogletown Stanton Rd Ste 217, Newark, DE 19713-2074 Ph: (302) 733-2410 |
News Archive
Percutaneous cryoablation, a relatively non-invasive technique that destroys tumors by freezing them, is a safe method for treating kidney tumors in selected patients who are not considered candidates for surgery, according to a new study by researchers from the Mayo Clinic in Rochester, MN.
Managing the activity of the BCAP protein could help the body repair intestinal tissue from damage caused by inflammation, according to a new study led by experts at Cincinnati Children's.
Caraco Pharmaceutical Laboratories, Ltd. generated net sales of $97.8 million and $227.8 million during the second quarter ended September 30, 2010 and first six months of the Company's current fiscal year ended September 30, 2010, respectively, as compared to $78.4 million and $126.4 million, respectively, for the corresponding periods of the previous fiscal year ended September 30, 2009.
NYC REACH, the Regional Extension Center overseen by the Primary Care Information Project at the NYC Health Department, has selected the Criterions EHR as a partner company. The NYC REACH program is designed to assist metropolitan practices with the adoption of EHR technology and the achievement of government Meaningful Use incentives.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced financial results for the three-month period ended September 30, 2010 - the first quarter of the Company's 2011 fiscal year (1QFY11).
› Verified 9 days ago
Amy Wallig Parosky, MSN, RNC, NNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4755 Ogletown-stanton Rd, Room 2410, Newark, DE 19718 Phone: 302-733-2359 Fax: 302-733-5168 | |
Kathy Elaine Gallagher, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4735 Ogletown-stanton Rd, Map2, Ste 3301, Newark, DE 19713 Phone: 302-623-4370 Fax: 302-623-4375 | |
Adeyoyin R Esaka, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Room E1070 Center For Heart & Vascular Health At Christ, Newark, DE 19718 Phone: 302-623-1929 Fax: 302-733-4533 | |
Muriel P Jurasevich, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-1000 | |
Karen M Smith, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4765 Ogletown Stanton Rd, Suite 1e20, Newark, DE 19713 Phone: 302-733-5700 Fax: 302-733-5775 | |
Mrs. Michelle Denise Septer, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-4621 Fax: 302-733-4287 | |
Susan Eileen Petrillo, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4755 Ogletown Stanton Rd, 3d38, Newark, DE 19718 Phone: 302-733-5628 Fax: 302-733-3887 |